Daniel Einhorn

15.4k total citations · 7 hit papers
43 papers, 7.4k citations indexed

About

Daniel Einhorn is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Daniel Einhorn has authored 43 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Molecular Biology and 8 papers in Surgery. Recurrent topics in Daniel Einhorn's work include Diabetes Management and Research (29 papers), Diabetes Treatment and Management (23 papers) and Hyperglycemia and glycemic control in critically ill and hospitalized patients (10 papers). Daniel Einhorn is often cited by papers focused on Diabetes Management and Research (29 papers), Diabetes Treatment and Management (23 papers) and Hyperglycemia and glycemic control in critically ill and hospitalized patients (10 papers). Daniel Einhorn collaborates with scholars based in United States, Australia and Cyprus. Daniel Einhorn's co-authors include Guillermo E. Umpierrez, George Grunberger, Yehuda Handelsman, Irl B. Hirsch, Alan J. Garber, Zachary T. Bloomgarden, Etie S. Moghissi, Paul S. Jellinger, Janet B. McGill and Silvio E. Inzucchi and has published in prestigious journals such as Diabetes Care, Frontiers in Endocrinology and Journal of the American Heart Association.

In The Last Decade

Daniel Einhorn

42 papers receiving 6.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on Inpatient Glycemic Control

2009 963 citations Etie S. Moghissi, Mary T. Korytkowski et al. Diabetes Care profile →
American College of Endocrinology Position Statement on the Insulin Resistance Syndrome

2003 764 citations Daniel Einhorn Endocrine Practice profile →
Statement by an American Association of Clinical Endocrinologists/ American College of Endocrinology Consensus Panel on Type 2 Diabetes Mellitus: An Algorithm for Glycemic Control

2009 751 citations Paul S. Jellinger, Jaime A. Davidson et al. Endocrine Practice profile →
Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2020 Executive Summary

2020 411 citations Alan J. Garber, Yehuda Handelsman et al. Endocrine Practice profile →
Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2018 Executive Summary

2018 377 citations Alan J. Garber, Martin J. Abrahamson et al. Endocrine Practice profile →
Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive type 2 Diabetes Management Algorithm – 2017 Executive Summary

2017 327 citations Alan J. Garber, Martin J. Abrahamson et al. Endocrine Practice profile →
Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2019 Executive Summary

2019 225 citations Alan J. Garber, Martin J. Abrahamson et al. Endocrine Practice profile →

Peers

Countries citing papers authored by Daniel Einhorn

Since Specialization

Citations

This map shows the geographic impact of Daniel Einhorn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Einhorn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Einhorn more than expected).

Fields of papers citing papers by Daniel Einhorn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Einhorn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Einhorn. The network helps show where Daniel Einhorn may publish in the future.

Co-authorship network of co-authors of Daniel Einhorn

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Einhorn. A scholar is included among the top collaborators of Daniel Einhorn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Einhorn. Daniel Einhorn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Management of Dyslipidemia and Prevention of Cardiovascular Disease Algorithm – 2020 Executive Summary 2020 ·Endocrine Practice ·Yehuda Handelsman, Paul S. Jellinger, Chris Guerin, Zachary T. Bloomgarden, Eliot A. Brinton, Matthew J. Budoff, Michael H. Davidson, Daniel Einhorn, Sergio Fazio, Vivian Fonseca, Alan J. Garber, George Grunberger, Ronald M. Krauss, Jeffrey I. Mechanick, Paul D. Rosenblit, Donald A. Smith, Kathleen Wyne	150
2	Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2018 Executive Summary breakdown → 2018 ·Endocrine Practice ·Alan J. Garber, Martin J. Abrahamson, Joshua I. Barzilay, Lawrence Blonde, Zachary T. Bloomgarden, Michael A. Bush, Samuel Dagogo‐Jack, Ralph A. DeFronzo, Daniel Einhorn, Vivian Fonseca, Jeffrey R. Garber, W. Timothy Garvey, George Grunberger, Yehuda Handelsman, Irl B. Hirsch, Paul S. Jellinger, Janet B. McGill, Jeffrey I. Mechanick, Paul D. Rosenblit, Guillermo E. Umpierrez	377
3	Revisiting The Use of Pioglitazone in the Treatment of Type 2 Diabetes 2016 ·Endocrine Practice ·Daniel Einhorn, Vivian Fonseca	4
4	AACE/ACE Comprehensive Diabetes Management Algorithm 2015 2015 ·Endocrine Practice ·Alan J. Garber, Martin J. Abrahamson, Joshua I. Barzilay, Lawrence Blonde, Zachary T. Bloomgarden, Michael A. Bush, Samuel Dagogo‐Jack, Michael Davidson, Daniel Einhorn, Jeffrey R. Garber, W. Timothy Garvey, George Grunberger, Yehuda Handelsman, Irl B. Hirsch, Paul S. Jellinger, Janet B. McGill, Jeffrey I. Mechanick, Paul D. Rosenblit, Guillermo E. Umpierrez, Michael Davidson	179
5	Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm - 2015 Executive Summary 2015 ·Endocrine Practice ·Alan J. Garber, Martin J. Abrahamson, Joshua I. Barzilay, Lawrence Blonde, Zachary T. Bloomgarden, Michael A. Bush, Samuel Dagogo‐Jack, Michael Davidson, Daniel Einhorn, Jeffrey R. Garber, (unknown), George Grunberger, Yehuda Handelsman, Irl B. Hirsch, Paul S. Jellinger, Janet B. McGill, Jeffrey I. Mechanick, Paul D. Rosenblit, Guillermo E. Umpierrez	40
6	American Association of Clinical Endocrinologists and American College of Endocrinology Consensus Conference on Obesity: Building an Evidence Base for Comprehensive Action 2014 ·Endocrine Practice ·W. Timothy Garvey, Alan J. Garber, Jeffrey I. Mechanick, George A. Bray, Samuel Dagogo‐Jack, Daniel Einhorn, George Grunberger, Yehuda Handelsman, Charles H. Hennekens, Daniel L. Hurley, Janet B. McGill, Pasquale Palumbo, Guillermo E. Umpierrez	26
7	American Association of Clinical Endocrinologists and American College of Endocrinology Position Statement on the 2014 Advanced Framework for a New Diagnosis of Obesity as a Chronic Disease 2014 ·Endocrine Practice ·W. Timothy Garvey, Alan J. Garber, Jeffrey I. Mechanick, George A. Bray, Samuel Dagogo‐Jack, Daniel Einhorn, George Grunberger, Yehuda Handelsman, Charles H. Hennekens, Daniel L. Hurley, Janet B. McGill, Pasquale Palumbo, Guillermo E. Umpierrez	172
8	Diabetes and Cancer—An AACE/ACE Consensus Statement 2013 ·Endocrine Practice ·Yehuda Handelsman, Derek LeRoith, Zachary T. Bloomgarden, Samuel Dagogo‐Jack, Daniel Einhorn, Alan J. Garber, George Grunberger, R. Mack Harrell, Robert F. Gagel, Harold E. Lebovitz, Janet B. McGill, Charles H. Hennekens	67
9	American Association of Clinical Endocrinologists' Comprehensive Diabetes Management Algorithm 2013 Consensus Statement - Executive Summary 2013 ·Endocrine Practice ·Alan J. Garber, Martin J. Abrahamson, Joshua I. Barzilay, Lawrence Blonde, Zachary T. Bloomgarden, Michael A. Bush, Samuel Dagogo‐Jack, Michael Davidson, Daniel Einhorn, W. Timothy Garvey, George Grunberger, Yehuda Handelsman, Irl B. Hirsch, Paul S. Jellinger, Janet B. McGill, Jeffrey I. Mechanick, Paul D. Rosenblit, Guillermo E. Umpierrez, Michael Davidson	240
10	The Clinical Approach to the Detection of Lipodystrophy an Aace Consensus Statement 2013 ·Endocrine Practice ·Yehuda Handelsman, Elif A Oral, Zachary T. Bloomgarden, Rebecca J. Brown, Jean L. Chan, Daniel Einhorn, Alan J. Garber, Abhimanyu Garg, W. Timothy Garvey, George Grunberger, Robert R. Henry, Norman Lavin, (unknown), Christian Weyer	83
11	Hypoglycemia in Type 2 Diabetes: Current Controversies and Changing Practices 2012 ·Frontiers in Endocrinology ·Zachary T. Bloomgarden, Daniel Einhorn	10
12	Hemoglobin A1C in Diabetes Diagnosis: Time for Caution 2010 ·Endocrine Practice ·Zachary T. Bloomgarden, Daniel Einhorn	9
13	American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on Inpatient Glycemic Control breakdown → 2009 ·Diabetes Care ·Etie S. Moghissi, Mary T. Korytkowski, Monica M. DiNardo, Daniel Einhorn, Richard Hellman, Irl B. Hirsch, Silvio E. Inzucchi, Faramarz Ismail‐Beigi, M. Sue Kirkman, Guillermo E. Umpierrez	963
14	AACE/ADA Consensus Statement 2009 ·Endocrine Practice ·Etie S. Moghissi, Mary T. Korytkowski, Monica M. DiNardo, Daniel Einhorn, Richard Hellman, Irl B. Hirsch, Silvio E. Inzucchi, Faramarz Ismail‐Beigi, M. Sue Kirkman, Guillermo E. Umpierrez	394
15	Prevalence of Sleep Apnea in a Population of Adults with Type 2 Diabetes Mellitus 2007 ·Endocrine Practice ·Daniel Einhorn, Deirdre A. Stewart, Milton K. Erman, Nancy Gordon, Athena Philis‐Tsimikas, (unknown)	180
16	Glitazones and the management of insulin resistance: what they do and how might they be used 2004 ·Endocrinology and Metabolism Clinics of North America ·Daniel Einhorn, Vanita R. Aroda, Robert R. Henry	19
17	EFFICACY AND SAFETY OF PIOGLITAZONE IN TYPE 2 DIABETES: A RANDOMISED, PLACEBO‐CONTROLLED STUDY IN PATIENTS RECEIVING STABLE INSULIN THERAPY 2002 ·International Journal of Clinical Practice ·Julio Rosenstock, Daniel Einhorn, Kenneth S. Hershon, N. Bradly Glazer, Shawn Yu	159
18	Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellitus: A randomized, placebo-controlled study 2000 ·Clinical Therapeutics ·Daniel Einhorn, Marc Rendell, James L. Rosenzweig, John Egan, Annette Mathisen, (unknown)	301
19	Office Logistics: Implementation of the Continuous Glucose Monitoring System in Clinical Practice 2000 ·Diabetes Technology & Therapeutics ·(unknown), Daniel Einhorn	4
20	Effect of Premixed Nph and Regular Insulin on Glucose Control and Health-Related Quality of Life in Patients with Type 2 Diabetes Mellitus 1997 ·Endocrine Practice ·Jaime A. Davidson, Daniel Einhorn, Pamela Allweiss, (unknown), Alan J. Garber, (unknown), Charles B. Kahn, (unknown), John R. White, William J. Huster	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact